Present-day anthelmintics and perspectives on future new targets

Parasitology Research

Volumn 113, Issue 7, 2014, Pages 2425-2433

  Taman, Amira ^a   Azab, Manar ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anthelmintics; Artemether; Flatworms; Nervous system; Praziquantel; Schistosoma mansoni

Indexed keywords

ALBENDAZOLE; AMODIAQUINE PLUS ARTESUNATE; ANTHELMINTIC AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; AVERMECTIN; BENZIMIDAZOLE; BITHIONOL; DIETHYLCARBAMAZINE; FLUBENDAZOLE; IVERMECTIN; LEVAMISOLE; NICLOSAMIDE; PIPERAQUINE; PIPERAZINE; PRAZIQUANTEL; PYRANTEL EMBONATE; TIABENDAZOLE; TRICLABENDAZOLE;

ANTHELMINTIC ACTIVITY; ASCARIS LUMBRICOIDES; BRUGIA MALAYI; BRUGIA TIMORI; CAPILLARIA PHILIPPINENSIS; CLONORCHIS SINENSIS; DIPHYLLOBOTHRIUM LATUM; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENTEROBIUS VERMICULARIS; FASCIOLA; FASCIOLA GIGANTICA; FASCIOLA HEPATICA; FASCIOLIASIS; HELMINTHIASIS; HUMAN; HYMENOLEPIS NANA; LOA LOA; LYMPHATIC FILARIASIS; MANSONELLA STREPTOCERCA; NERVOUS SYSTEM; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPISTHORCHIS; OPISTHORCHIS VIVERRINI; OXIDATIVE PHOSPHORYLATION; PARAGONIMIASIS; PARAGONIMUS WESTERMANI; PRIORITY JOURNAL; REINFECTION; REVIEW; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPASTIC PARESIS; STRONGYLOIDES STERCORALIS; TAENIA SAGINATA; TAENIA SOLIUM; THERAPY EFFECT; TRICHOSTRONGYLUS; TRICHURIS TRICHIURA; WUCHERERIA BANCROFTI;

BACTERIA (MICROORGANISMS); MAMMALIA; PLATYHELMINTHES; SCHISTOSOMA MANSONI; VERMES;

ANIMALS; ANTHELMINTICS; DRUG DISCOVERY; DRUG RESISTANCE; HELMINTHS; HUMANS; NERVOUS SYSTEM;

EID: 84903821575     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-014-3969-7     Document Type: Review

References (86)

1. Abdel Aziz SS, el-Badawy NM (2000) Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice. J Egypt Soc Parasitol 30:295-303
2. Abdul-Ghani R, Loutfy N, Sahn AE, Hassan A (2009) Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol Res 104:955-965
3. Abdul-Ghani R, Loutfy N, Sheta M, Hassan A (2011) Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. Parasitol Res 108:1199-1205
4. Addiss DG, Beach MJ, Streit TG, Lutwick S, Leconte FH, Lafontant JG, Hightower AW, Lammie PJ (1997) Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 350:480-484 (Pubitemid 27343303)
5. Albonico M, Bickle Q, Ramsan M, Montresor A, Savioli L, Taylor M (2003) Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Org 81:343-352 (Pubitemid 36644260)
6. Allen H, Crompton DWT, De Silva N, LoVerde PT, Olds GR (2002) New policies for using anthelmintics in high risk groups. Trends Parasitol 18:381-382
7. Angelucci F, Basso A, Bellelli A, Brunori M, Pica Mattoccia L, Valle C (2007) The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology 134:1215-1221 (Pubitemid 47174071)
8. Bergquist R, Utzinger J, Chollet J, Shu-Hua X, Weiss NA, Tanner M (2004) Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model. Am J Trop Med Hyg 71:774-777 (Pubitemid 40075629)
9. Bradley M, Horton J (2001) Assessing the risk of benzimidazole therapy during pregnancy. Trans R Soc Trop Med Hyg 95:72-73 (Pubitemid 34202230)
10. Calvopina M, Guderian RH, Paredes W, Chico M, Cooper PJ (1998) Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 92:566-569 (Pubitemid 28486493)
11. Carr AW, McCracken RO, Stillwell WH (1993) Uncoupling of rat liver mitochondrial oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites. J Parasitol 79:198-204 (Pubitemid 23136095)
12. Chai JY (2013) Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother 45:32-43
13. Craig P, Ito A (2007) Intestinal cestodes. Curr Opin Infect Dis 20:524-532 (Pubitemid 47359651)
14. Cross HF, Haarbrink M, Egerton G, Yazdanbakhsh M, Taylor MJ (2001) Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 358:1873-1875 (Pubitemid 34008657)
15. Cully DF, Paress PS, Liu KK, Schaeffer JM, Arena JP (1996) Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin. J Biol Chem 271:20187-20191 (Pubitemid 26281776)
16. Cupp EW, Sauerbrey M, Richards F (2010) Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan®) monotherapy. Acta Trop 120:S100-S108
17. D'Angelo JG, Bordón C, Posner GH, Yolken R, Jones-Brando L (2009) Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother 63:146-150
18. De Silva NR, Sirisena JLGJ, Gunasekera DPS, Ismail MM, De Silva HJ (1999) Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 353:1145-1149 (Pubitemid 29155208)
19. Diab TM, Mansour HH, Mahmoud SS (2010) Fasciola gigantica: parasitological and scanning electron microscopy study of the in vitro effects of ivermectin and/or artemether. Exp Parasitol 124:279-284
20. El-Beshbishi SN, Taman A, El-Malky M, Azab MS, El-Hawary AK, El-Tantawy DA (2013a) In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain. Exp Parasitol 135:240-245
21. El-Beshbishi SN, Taman A, El-Malky M, Azab MS, El-Hawary AK, El-Tantawy DA (2013b) First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection. Int J Parasitol 43:521-530
22. El-Bialy S, Taman A, El-Beshbishi S, Mansour B, El-Malky M, Bayoumi W, Essa H (2013) Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection. Parasitol Res 112:4221-4229
23. El-Morshedy H, Farghaly A, Sharaf S, Abou-Basha L, Barakat R (1999) Triclabendazole in the treatment of human fascioliasis: a community-based study. East Mediterr Health J 5:888-894
24. El-Shehabi F, Ribeiro P (2010) Histamine signalling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2). Int J Parasitol 40:1395-1406
25. El-Shehabi F, Vermeire JJ, Yoshino TP, Ribeiro P (2009) Developmental expression analysis and immunolocalization of a biogenic amine receptor in Schistosoma mansoni. Exp Parasitol 122:17-27
26. El-Shehabi F, Taman A, Moali LS, El-Sakkary N, Ribeiro P (2012) A novel g protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system. PLoS Neglect Trop Dis 6:e1523
27. Garcia HH (2008) Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? Expert Rev Anti Infect Ther 6:295-298
28. Geary TG, Mackenzie CD (2011) Progress and challenges in the discovery of macrofilaricidal drugs. Expert Rev Anti infect Ther 9:681-695
29. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, Prichard RK, de Silva NR, Olliaro PL, Lazdins-Helds JK, Engels DA, Bundy DA (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40:1-13
30. Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE (2006) Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 36:1427-1441 (Pubitemid 44751746)
31. 2+ channels targets of praziquantel action? Int J Parasitol 35:1-9
32. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA (2005) Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 6:179-200 (Pubitemid 40305333)
33. Halton DW (1996) Functional morphology of the platyhelminth nervous system. Parasitology 113:S47-S72
34. Hamdan FF, Abramovitz M, Mousa A, Xie J, Durocher Y, Ribeiro P (2002) A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Mol Biochem Parasitol 119:75-86 (Pubitemid 34038027)
35. Hombhanje FW, Huang Q (2010) Artemisinin-naphthoquine combination (ARCO®): an overview of the progress. Pharmaceuticals 3:3581-3593
36. Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyer G, Sapuri M (2009) Artemisininnaphthoquine combination (ARCO®) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J 8:196-304
37. James DM, Gilles HM (1985) Human antiparasitic drugs: pharmacology and usage. Wiley, New York
38. Keiser J, Utzinger J (2007a) Advances in the discovery and development of trematocidal drugs. Expert Opin Drug Discov 2:S9-S23 (Pubitemid 47616028)
39. Keiser J, Utzinger J (2007b) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis 20:605-612 (Pubitemid 350059520)
40. Keiser J, Utzinger J (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and metaanalysis. JAMA 299:1937-1948 (Pubitemid 351574924)
41. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Taylor MJ, Nutman TB (2002) Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 185:805-811 (Pubitemid 34226208)
42. Keiser J, El Ela NA, El Komy E, El Lakkany N, Diab T, Chollet J, Utzinger J, Barakat R (2006) Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model. Am J Trop Med Hyg 75:287-291 (Pubitemid 46941346)
43. Kim JS (1970) Treatment of Paragonimus westermani infections with bithionol. Am J Trop Med Hyg 19:940-942
44. Kohn AB, Anderson PAV, Roberts-Misterly JM, Greenberg RM (2001) Schistosome calcium channel β subunits: unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J Biol Chem 276:36873-36876
45. Krishna S, Bustamante L, Haynes RK, Staines HM (2008) Artemisinins: their growing importance in medicine. Trends Pharmacol Sci 29:520-527
46. Lacey E (1990) Mode of action of benzimidazoles. Parasitol Today 6:112-115
47. Li HJ, Wang W, Li YZ, Qu GL, Xing YT, Tao YH, Wei JY, Dai JR, Liang YS (2011) Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. Parasitol Res 109:515-519
48. Li HJ, Wang W, Qu GL, Li YZ, Tao YH, Xing YT, Wang XT, Dai Y, Wei JY, Dai JR, Coles GC, Liang YS (2012) Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol Res 110:1727-1732
49. Liu R, Dong HF, Guo Y, Zhao QP, Jiang MS (2011) Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and metaanalysis. Parasitol Vectors 4:201-218
50. Mackenzie CD, Geary TG (2011) Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Expert Rev Anti Infect Ther 9:497-501
51. Martin RJ, Robertson AP (2010) Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery. Adv Exp Med Biol 692:138-154
52. Martin RJ, Robertson AP, Bjorn H (1997) Target sites of anthelmintics. Parasitology 114:S111-S124
53. McGarry HF, Plant LD, Taylor MJ (2005) Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J 4:4
54. Mehlhorn H, Becker B, Andrews P, Thomas H, Frenkel JK (1981) In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study. Arzneim Forsch/Drug Res 31:544-554 (Pubitemid 11057120)
55. Mendonça-Silva DL, Pesso RF, Noel F (2002) Evidence for the presence of glutamatergic receptors in adult Schistosoma mansoni. Biochem Pharmacol 64:1337-1344 (Pubitemid 35248251)
56. Mishina YV, Krishna S, Haynes RK, Meade JC (2007) Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrob Agents Chemother 51:1852-1854 (Pubitemid 46744172)
57. Montresor A, Awasthi S, Crompton DWT (2003) Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis. Acta Trop 86:223-232 (Pubitemid 36561370)
58. Nibret E, Wink M (2010) Volatile components of four Ethiopian Artemisia species extracts and their in vitro antitrypanosomal and cytotoxic activities. Phytomedicine 17:369-374
59. Oliveira MF, D'Avila JCP, Tempone AJ, Corrêa Soares JBR, Rumjanek FD, Ferreira-Pereira A, Ferreira ST, Oliveira PL (2004) Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection. J Infect Dis 190:843-852 (Pubitemid 39050016)
60. Ottesen EA, Hooper PJ, Bradley M, Biswas G (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2:e317
61. Pacqué M, Munoz B, Poetschke G, Foose J, Greene BM, Taylor HR (1990) Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 336:1486-1489
62. Patocka N, Sharma N, Rashid M, Ribeiro P (2014) Serotonin signaling in Schistosoma mansoni: a serotonin-activated g protein-coupled receptor controls parasite movement. PLoS Pathog 10:e1003878
63. Pax RA (1996) Neuromuscular physiology and pharmacology of parasitic flatworms. Parasitology 113:S83-S96
64. Peixoto CA, Rocha A, Aguiar-Santos A, Florêncio MS (2004) The effects of diethylcarbamazine on the ultrastructure of microfilariae of Wuchereria bancrofti in vivo and in vitro. Parasitol Res 92:513-517 (Pubitemid 38658349)
65. Pica-Mattoccia L, Cioli D (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 34:527-533 (Pubitemid 38317176)
66. Renoux G (1980) The general immunopharmacology of levamisole. Drugs 20:89-99
67. Ribeiro P, El-Shehabi F, Patocka N (2005) Classical transmitters and their receptors in flatworms. Parasitology 131:S19-S40
68. Strong M, Johnstone PW (2007) Interventions for treating scabies. Cochrane Database of Syst Rev CD000320
69. Taman A, Ribeiro P (2009) Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. Mol Biochem Parasitol 168:24-33
70. Taman A, Ribeiro P (2011a) Glutamate-mediated signaling in Schistosoma mansoni: a novel glutamate receptor is expressed in neurons and the female reproductive tract. Mol Biochem Parasitol 176:42-50
71. Taman A, Ribeiro P (2011b) Characterization of a truncatedmetabotropic glutamate receptor in a primitive metazoan, the parasitic flatworm Schistosoma mansoni. PLoS ONE 6:e27119
72. Torres JR, Isturiz R, Murillo J, Guzman M, Contreras R (1993) Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 17:900-902 (Pubitemid 23321915)
73. Twum-Danso N (2003) Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future. Filaria J2:S7
74. Utzinger J, Chollet J, Tu Z, Shuhua X, Tanner M (2002) Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infectedmice. Trans R Soc Trop Med Hyg 96:318-323 (Pubitemid 34785073)
75. Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47:1487-1495 (Pubitemid 36548527)
76. van den Enden E (2009) Pharmacotherapy of helminth infection. Expert Opin Pharmacother 10:435-451
77. Weinbach EC, Garbus J (1969) Mechanism of action of reagents that uncouple oxidative phosphorylation. Nature 221:1016-1018
78. Wen H, Zhang HW, Muhmut M, Zou PF, New RRC, Craig PS (1994) Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Ann Trop Med Parasitol 88:49-52 (Pubitemid 24114087)
79. WHO (2006) Guidelines for the treatment of malaria, vol WHO/HTM/MAL/2006.1108. Switzerland, Geneva
80. WHO (2014a) Foodborne trematodiasis. Fact sheet N°368 [online] available from http://www.who.int/mediacentre/factsheets/fs368/en/ [Accessed on May, 2014]
81. WHO (2014b) Schistosomiasis. Fact sheet N°115 [online] available from http://www.who.int/mediacentre/factsheets/fs115/en/ [Accessed on May, 2014]
82. Williamson SM, Robertson AP, Brown L, Williams T, Woods DJ, Martin RJ, Sattelle DB, Wolstenholme AJ (2009) The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog 5:e1000517
83. Wolstenholme AJ, Rogers AT (2005) Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 131:S85-S95
84. Xiao SH, You JQ, Mei JY, Guo HF, Jiao PY, Sun HL, Yao MY, Feng Z (1997) Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum. Acta Pharmacol Sin 18:363-367
85. Xiao SH, Binggui S, Chollet J, Tanner M (2000) Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether. Acta Trop 75:341-348 (Pubitemid 30320872)
86. Xiao SH, Chollet J, Utzinger J, Matile H, Jinyan M, Tanner M (2001) Artemether administered together with haemin damages schistosomes in vitro. Trans R Soc Trop Med Hyg 95:67-71 (Pubitemid 34202229)